Restricted accessResearch articleFirst published online 2021-3
Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II
Objective: The aim of this study was to examine whether reaction time parameters in adult patients with ADHD could predict their response to methylphenidate (MPH). Method: Previously unmedicated patients (N = 123) were administered the Conners’ Continuous Performance Test II (CPT II) at baseline and after 6 weeks of treatment with immediate-release MPH. In addition to traditional CPT measures, we extracted intraindividual raw data and analyzed time series using linear and nonlinear mathematical models. Results: Clinical responders, assessed with the Clinical Global Impression-Improvement scale, showed significant normalization of target failures, reduced variability and skewness, and increased complexity of reaction time series after 6 weeks of treatment, while nonresponders showed no significant changes. Prior to treatment, responders had significantly higher variability and skewness, combined with lower complexity, compared with nonresponders. Conclusion: These results show that the CPT test is useful in the evaluation of treatment response to MPH.
AbikoffH.ArnoldL. E.NewcornJ. H.ElliottG. R.HechtmanL.SevereJ. B.. . . WellsK. C. (2002). Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: The MTA manual-based solution. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 498-504.
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
5.
BarkleyR. A. (2010). Differential diagnosis of adults with ADHD: The role of executive function and self-regulation. Journal of Clinical Psychiatry, 71, e17. doi:10.4088/JCP.9066tx1c
6.
BarkleyR. A.EdwardsG.LaneriM.FletcherK.MeteviaL. (2001). Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). Journal of Abnormal Child Psychology, 29, 541-556.
7.
BiedermanJ.FaraoneS. V. (2005). Attention-deficit hyperactivity disorder. The Lancet, 366, 237-248. doi:10.1016/s0140-6736(05)66915-2
8.
BiedermanJ.MickE.SurmanC.DoyleR.HammernessP.KotarskiM.SpencerT. (2010). A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 30, 549-553. doi:10.1097/JCP.0b013e3181ee84a7
9.
BiedermanJ.PettyC. R.EvansM.SmallJ.FaraoneS. V. (2010). How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Research, 177, 299-304. doi:S0165-1781(09)00519-8
10.
BiedermanJ.PettyC. R.FriedR.FontanellaJ.DoyleA. E.SeidmanL. J.FaraoneS. V. (2006). Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 163, 1730-1738. doi:163/10/1730
11.
BiedermanJ.PettyC. R.O’ConnorK. B.HyderL. L.FaraoneS. V. (2012). Predictors of persistence in girls with attention deficit hyperactivity disorder: Results from an 11-year controlled follow-up study. Acta Psychiatrica Scandinavica, 125, 147-156. doi:10.1111/j.1600-0447.2011.01797.x
12.
BuitelaarJ. K.KooijJ. J.Ramos-QuirogaJ. A.DejonckheereJ.CasasM.van OeneJ. C.. . . TrottG. E. (2011). Predictors of treatment outcome in adults with ADHD treated with OROS(R) methylphenidate. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 554-560. doi:S0278-5846(10)00510-5
13.
BuitelaarJ. K.Van Der GaagR. J.Swaab-barnkvhldH.KuipkrM. A. (1995). Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 1025-1032. doi:10.1080/15374416.2016.1228461
14.
BusnerJ.TargumS. D. (2007). The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont), 4, 28-37.
CastellanosF. X.Sonuga-BarkeE. J.ScheresA.DiM. A.HydeC.WaltersJ. R. (2005). Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biological Psychiatry, 57, 1416-1423.
17.
ChazanR.BorowskiC.PiancaT.LudwigH.RohdeL. A.PolanczykG. (2011). Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country. Journal of Clinical Psychopharmacology, 31, 309-317. doi:10.1097/JCP.0b013e318217b4df
18.
CoghillD. R.NiggJ.RothenbergerA.Sonuga-BarkeE.TannockR. (2005). Whither causal models in the neuroscience of ADHD?Developmental Science, 8, 105-114. doi:10.1111/j.1467-7687.2005.00397.x
19.
CoghillD. R.RhodesS. M.MatthewsK. (2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62, 954-962. doi:10.1016/j.biopsych.2006.12.030
20.
CoghillD. R.SethS.MatthewsK. (2014). A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: Advancing beyond the three-pathway models. Psychological Medicine, 44, 1989-2001. doi:10.1017/s0033291713002547
21.
ConnersC. K.EisenbergL.BarcaiA. (1967). Effect of dextroamphetamine on children. Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry, 17, 478-485. doi:10.1001/archpsyc.1967.01730280094011
22.
ConnersC. K.EpsteinJ. N.AngoldA.KlaricJ. (2003). Continuous performance test performance in a normative epidemiological sample. Journal of Abnormal Child Psychology, 31, 555-562. doi:10.1023/A:1025457300409
23.
ConnersC. K.StaffM.ConnellyV.CampbellS.MacLeanM.BarnesJ. (2000). Conners’ continuous performance Test II (CPT II v. 5). Multi-Health Systems Inc, 29, 175-196.
24.
CunillR.CastellsX.TobiasA.CapellàD. (2016). Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: A meta-analysis and meta-regression in over 9000 patients. Psychopharmacology, 233, 187-197. doi:10.1007/s00213-015-4099-3
25.
del CampoN.ChamberlainS. R.SahakianB. J.RobbinsT. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry, 69, e145-e157. doi:10.1016/j.biopsych.2011.02.036
26.
EgelandJ.Kovalik-GranI. (2010). Validity of the factor structure of Conners’ CPT. Journal of Attention Disorders, 13, 347-357. doi:1087054709332477
27.
EpsteinJ. N.ErkanliA.ConnersC. K.KlaricJ.CostelloJ. E.AngoldA. (2003). Relations between Continuous Performance Test performance measures and ADHD behaviors. Journal of Abnormal Child Psychology, 31, 543-554. doi:10.1023/A:1025405216339
28.
FaraoneS. V.BiedermanJ.MickE. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36, 159-165. doi:10.1017/S003329170500471X
29.
FaraoneS. V.GlattS. J. (2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry, 71, 754-763. doi:10.4088/JCP.08m04902pur
30.
FasmerO. B.MjeldheimK.FørlandW.HansenA. L.SyrstadV. E. G.OedegaardK. J.BerleJ. Ø. (2016). Linear and non-linear analyses of Conner’s continuous performance test-II discriminate adult patients with attention deficit hyperactivity disorder from patients with mood and anxiety disorders. BMC Psychiatry, 16, Article 284. doi:10.1186/s12888-016-0993-4
31.
FredriksenM.DahlA. A.MartinsenE. W.KlungsoyrO.FaraoneS. V.PeleikisD. E. (2014). Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Attention Deficit and Hyperactivity Disorders, 6, 87-99. doi:10.1007/s12402-014-0126-1
32.
FredriksenM.DahlA. A.MartinsenE. W.KlungsoyrO.HaavikJ.PeleikisD. E. (2014). Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidity. European Neuropsychopharmacology, 24, 1873-1884.
33.
FredriksenM.HalmoyA.FaraoneS. V.HaavikJ. (2013). Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies. European Neuropsychopharmacology, 23, 508-527.
34.
GarrettD. D.KovacevicN.McIntoshA. R.GradyC. L. (2010). Blood oxygen level-dependent signal variability is more than just noise. Journal of Neuroscience, 30, 4914-4921.
35.
GoldbergerA. L.AmaralL. A.GlassL.HausdorffJ. M.IvanovP. C.MarkR. G.. . . StanleyH. E. (2000). Physiobank, physiotoolkit, and physionet. Circulation, 101, e215-e220.
36.
GuyW. (1976). ECDEU assessment manual for psychopharmacology (Vol. 76). Rockville, Md: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
HaavikJ.HalmoyA.LundervoldA. J.FasmerO. B. (2010). Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 10, 1569-1580. doi:10.1586/ern.10.149
39.
HartH.ChantilukeK.CubilloA. I.SmithA. B.SimmonsA.BrammerM. J.. . . RubiaK. (2014). Pattern classification of response inhibition in ADHD: Toward the development of neurobiological markers for ADHD. Human Brain Mapping, 35, 3083-3094. doi:10.1002/hbm.22386
40.
HaugeE. R.BerleJ. Ø.OedegaardK. J.HolstenF.FasmerO. B. (2011). Nonlinear analysis of motor activity shows differences between schizophrenia and depression: A study using Fourier analysis and sample entropy. PLoS ONE, 6, e16291. doi:10.1371/journal.pone.0016291
41.
Ishii-TakahashiA.TakizawaR.NishimuraY.KawakuboY.HamadaK.OkuhataS.. . . TodokoroA. (2015). Neuroimaging-aided prediction of the effect of methylphenidate in children with attention-deficit hyperactivity disorder: A randomized controlled trial. Neuropsychopharmacology, 40, 2676-2685. doi:10.1038/npp.2015.128
42.
JohnsonK. A.BarryE.BellgroveM. A.CoxM.KellyS. P.DáibhisA.. . . FitzgeraldM. (2008). Dissociation in response to methylphenidate on response variability in a group of medication naive children with ADHD. Neuropsychologia, 46, 1532-1541. doi:10.1016/j.neuropsychologia.2008.01.002
43.
JohnsonK. A.KellyS. P.BellgroveM. A.BarryE.CoxM.GillM.RobertsonI. H. (2007). Response variability in attention deficit hyperactivity disorder: Evidence for neuropsychological heterogeneity. Neuropsychologia, 45, 630-638. doi:10.1016/j.neuropsychologia.2006.03.034
44.
JohnstonB. A.CoghillD.MatthewsK.SteeleJ. D. (2015). Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study. Journal of Psychopharmacology, 29, 24-30. doi:10.1177/0269881114548438
45.
KaasinenV.RinneJ. O. (2002). Functional imaging studies of dopamine system and cognition in normal aging and Parkinson’s disease. Neuroscience & Biobehavioral Reviews, 26, 785-793.
46.
KaiserS.RothA.RentropM.FriederichH.-C.BenderS.WeisbrodM. (2008). Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain and Cognition, 66, 73-82. doi:10.1016/j.bandc.2007.05.007
47.
KesslerR. C.AdlerL. A.BarkleyR.BiedermanJ.ConnersC. K.FaraoneS. V.. . . ZaslavskyA. M. (2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biological Psychiatry, 57, 1442-1451.
48.
KimJ.-W.SharmaV.RyanN. D. (2015). Predicting methylphenidate response in ADHD using machine learning approaches. International Journal of Neuropsychopharmacology, 18, pyv052. doi:10.1093/ijnp/pyv052
49.
KoflerM. J.RapportM. D.SarverD. E.RaikerJ. S.OrbanS. A.FriedmanL. M.KolomeyerE. G. (2013). Reaction time variability in ADHD: A meta-analytic review of 319 studies. Clinical Psychology Review, 33, 795-811. doi:10.1016/j.cpr.2013.06.001
50.
KooijJ. J. S.BurgerH.BoonstraA. M.Van der LindenP. D.KalmaL. E.BuitelaarJ. K. (2004). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder: A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine, 34, 973-982.
51.
KooijJ. J. S. (2012). Diagnostic assessment and treatment. Adult ADHD. 3rd ed.London: Springer-Verlag. doi:10.1007/978-1-4471-4138-9
52.
LaraC.FayyadJ.DeG. R.KesslerR. C.Aguilar-GaxiolaS.AngermeyerM.. . . SampsonN. (2009). Childhood predictors of adult attention-deficit/hyperactivity disorder: Results from the World Health Organization World Mental Health Survey Initiative. Biological Psychiatry, 65, 46-54.
53.
LeeR. W.JacobsonL. A.PritchardA. E.RyanM. S.YuQ.DencklaM. B.. . . MahoneE. M. (2015). Jitter reduces response-time variability in ADHD: An ex-Gaussian analysis. Journal of Attention Disorders, 19, 794-804. doi:10.1177/1087054712464269
54.
LeeS. H.SongD. H.KimB. N.JoungY. S.HaE. H.CheonK. A.. . . ShinD. W. (2009). Variability of response time as a predictor of methylphenidate treatment response in Korean children with attention deficit hyperactivity disorder. Yonsei Medical Journal, 50, 650-655. doi:10.3349/ymj.2009.50.5.650
55.
LloydA.HodgkinsP.SasaneR.AkehurstR.Sonuga-BarkeE. J.FitzgeraldP.. . . BrazierJ. (2011). Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient, 4, 247-257. doi:10.2165/11592150-000000000-00000
56.
LosierB. J.McGrathP. J.KleinR. M. (1996). Error patterns on the continuous performance test in non medicated and medicated samples of children with and without ADHD: A meta analytic review. Journal of Child Psychology and Psychiatry, 37, 971-987.
57.
MacDonaldS. W.NybergL.BäckmanL. (2006). Intra-individual variability in behavior: Links to brain structure, neurotransmission and neuronal activity. Trends in Neurosciences, 29, 474-480. doi:10.1016/j.tins.2006.06.011
58.
McIntoshA. R.KovacevicN.ItierR. J. (2008). Increased brain signal variability accompanies lower behavioral variability in development. PLoS Computational Biology, 4(7), e1000106. doi:10.1371/journal.pcbi.1000106
59.
McMahonF. J. (2014). Prediction of treatment outcomes in psychiatry—Where do we stand?Dialogues in Clinical Neuroscience, 16, 455.
60.
MoffittT. E.HoutsR.AshersonP.BelskyD. W.CorcoranD. L.HammerleM.. . . PolanczykG. V. (2015). Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. American Journal of Psychiatry, 172, 967-977. doi:10.1176/appi.ajp.2015.14101266
61.
MorrisS. B.DeShonR. P. (2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods, 7, 105-125.
62.
MowinckelA. M.AlnaesD.PedersenM. L.ZieglerS.FredriksenM.KaufmannT.. . . BieleG. (2017). Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD. Neuroimage: Clinical, 16, 369-382. doi:10.1016/j.nicl.2017.03.008
63.
Mujica-ParodiL.YeraganiV.MalaspinaD. (2005). Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia1. Neuropsychobiology, 51, 10-15. doi:10.1159/000082850
64.
NiggJ. T. (2013). Attention-deficit/hyperactivity disorder and adverse health outcomes. Clinical Psychology Review, 33, 215-228. doi:10.1016/j.cpr.2012.11.005
65.
NoreikaV.FalterC. M.RubiaK. (2013). Timing deficits in attention-deficit/hyperactivity disorder (ADHD): Evidence from neurocognitive and neuroimaging studies. Neuropsychologia, 51, 235-266. doi:10.1016/j.neuropsychologia.2012.09.036
66.
ParkS.KimB. N.ChoS. C.KimJ. W.ShinM. S.YooH. J.. . . CheongJ. H. (2013). Baseline severity of parent-perceived inattentiveness is predictive of the difference between subjective and objective methylphenidate responses in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 23, 410-414. doi:10.1089/cap.2013.0031
67.
PerryG. M.SagvoldenT.FaraoneS. V. (2010). Intraindividual variability (IIV) in an animal model of ADHD-the Spontaneously Hypertensive Rat. Behavioral and Brain Functions, 6, Article 56. doi:10.1186/1744-9081-6-56
68.
PolanczykG.de LimaM. S.HortaB. L.BiedermanJ.RohdeL. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.
69.
PortaA.TobaldiniE.GuzzettiS.FurlanR.MontanoN.Gnecchi-RusconeT. (2007). Assessment of cardiac autonomic modulation during graded head-up tilt by symbolic analysis of heart rate variability. American Journal of Physiology-Heart and Circulatory Physiology, 293, 702-708. doi:10.1152/ajpheart.00006.2007
70.
RabinL. A.SpadacciniA. T.BrodaleD. L.GrantK. S.Elbulok-CharcapeM. M.BarrW. B. (2014). Utilization rates of computerized tests and test batteries among clinical neuropsychologists in the United States and Canada. Professional Psychology: Research and Practice, 45, 368. doi:10.1037/a0037987
71.
RiccioC. A.WaldropJ. J.ReynoldsC. R.LoweP. (2001). Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation. The Journal of Neuropsychiatry and Clinical Neurosciences, 13, 326-335. doi:10.1176/jnp.13.3.326
72.
RichmanJ. S.MoormanJ. R. (2000). Physiological time-series analysis using approximate entropy and sample entropy. American Journal of Physiology-Heart and Circulatory Physiology, 278, 2039-2049. doi:10.1152/ajpheart.2000.278.6.H2039
73.
RoschK. S.DirlikovB.MostofskyS. H. (2015). Reduced intrasubject variability with reinforcement in boys, but not girls, with ADHD: Associations with prefrontal anatomy. Biological Psychology, 110, 12-23. doi:10.1016/j.biopsycho.2015.06.010
74.
RoslerM.FischerR.AmmerR.OseC.RetzW. (2009). A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience, 259, 120-129. doi:10.1007/s00406-008-0845-4
75.
RosvoldH. E.MirskyA. F.SarasonI.BransomeE. D.Jr.BeckL. H. (1956). A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350.
76.
SchranteeA.TammingaH. G.BouzianeC.BottelierM. A.BronE. E.MutsaertsH.-J. M.. . . LindauerR. J. (2016). Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit/hyperactivity disorder: A randomized clinical trial. JAMA Psychiatry, 73, 955-962. doi:10.1001/jamapsychiatry.2016.1572
77.
SergeantJ. A.GeurtsH.HuijbregtsS.ScheresA.OosterlaanJ. (2003). The top and the bottom of ADHD: A neuropsychological perspective. Neuroscience & Biobehavioral Reviews, 27, 583-592.
78.
SetyawanJ.FridmanM.HodgkinsP.QuinteroJ.ErderM. H.KatićB. J.HarpinV. (2015). Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: A physician perspective. ADHD Attention Deficit and Hyperactivity Disorders, 7, 75-87. doi:10.1007/s12402-014-0143-0
79.
SheehanD.JanavsJ.BakerR.Harnett-SheehanK.KnappE.SheehanN. (2002). MINI PLUS. Mini international neuropsychiatric interview (Norwegian version). Tampa: Institute for Research in Psychiatry, University of South Florida.
80.
StuhecM.MundaB.SvabV.LocatelliI. (2015). Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion. Journal of Affective Disorders, 178, 149-159. doi:10.1016/j.jad.2015.03.006
81.
TreuerT.FengQ.DesaiahD.AltinM.WuS.El-ShafeiA.. . . FariesD. (2014). Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates. International Journal of Clinical Practice, 68, 1152-1160. doi:10.1111/ijcp.12437
82.
UrbanK. R.GaoW.-J. (2015). Evolution of the study of methylphenidate and its actions on the adult versus juvenile brain. Journal of Attention Disorders, 19, 603-619. doi:10.1177/1087054712455504
83.
VaurioR. G.SimmondsD. J.MostofskyS. H. (2009). Increased intra-individual reaction time variability in attention-deficit/hyperactivity disorder across response inhibition tasks with different cognitive demands. Neuropsychologia, 47, 2389-2396. doi:10.1016/j.neuropsychologia.2009.01.022
84.
VitolaE. S.BauC. H.SalumG. A.HortaB. L.QuevedoL.BarrosF. C.. . . GrevetE. H. (2017). Exploring DSM-5 ADHD criteria beyond young adulthood: Phenomenology, psychometric properties and prevalence in a large three-decade birth cohort. Psychological Medicine, 47, 744-754. doi:10.1017/s0033291716002853
85.
WassersteinJ. (2005). Diagnostic issues for adolescents and adults with ADHD. Journal of Clinical Psychology, 61, 535-547. doi:10.1002/jclp.20118
86.
WillcuttE. G.NiggJ. T.PenningtonB. F.SolantoM. V.RohdeL. A.TannockR.. . . LaheyB. B. (2012). Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. Journal of Abnormal Psychology, 121, 991-1010.
87.
WongH. K.TiffinP. A.ChappellM. J.NicholsT. E.WelshP. R.DoyleO. M.. . . ShenY. (2017). Personalized medication response prediction for attention-deficit hyperactivity disorder: Learning in the model space vs. learning in the data space. Frontiers in Physiology, 11, Article 199. doi:10.3389/fphys.2017.00199
88.
ZhuangJ.NingX.DuS.WangZ.HuoC.YangX.FanA. (2008). Nonlinear short-term heart rate variability prediction of spontaneous ventricular tachyarrhythmia. Chinese Science Bulletin, 53, 2446-2453.
89.
ZweigM. H.CampbellG. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry, 39, 561-577.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
